Moreover, it was demonstrated that PLCε expression is usually downregulated in RAS-driven cancers, such as colon cancer, and that its overexpression was associated with reduction in the proliferation of skin cancer cells in vivo [115]. The gene discussed is PLCE1; the disease is cancer.